PEOPLE - NextGen Group makes appointment:
This article was originally published in Clinica
NextGen Group (Huntingdon, UK) has appointed Jake Orville as vice-president of global sales. He will be responsible for driving commercialisation of the firm's products in the US, Europe and the Far East. The company, which recently acquired Proteomic Research Services (US), develops systems, services and reagents to enable enhanced access to, and understanding of, the role of proteins in diagnosis and drug discovery.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.